Owner Bavarian Nordic A/S

Convention EP 18 March 2005 004348728

Various Convention priority claimed: 8 August 2005, Denmark, No. VA 2005 03259 in respect of CLASS: 01.* Convention priority claimed: 18 March 2005, European Patent Office (EPO), No. 004348728 in respect of CLASS: 05.

Filing Date 16 September 2005

Class 1 Molecular vectors for gene therapy use; biochemical adjuvants to increase the efficacy/activity of vaccines and drugs; molecular antigens to induce the formation of antibodies in a cell for use in immunology research; viruses, including recombinant viruses, other than for medical or veterinary use; chemical and biochemical substances

Class 5 Pharmaceutical and veterinary preparations, in particular, preparations for the treatment and prevention of infectious diseases, viral diseases, poxvirus diseases, smallpox, tumor diseases allergies; preparations for stimulating and modulating the immune system; preparations for accelerating the maturation of the immune system; preparations for the treatment and prevention of cancer, AIDS, pneumonia, bronchiolitis, respiratory diseases, Dengue fever, inflammatory diseases, including rheumatism and arthritis/neuritis, dermatological diseases, including Psoriasis and allergic skin eczema, dementia, mental retardation diseases; vaccines; vaccine vectors and drug candidates; vaccine adjuvants

Class 42 Development of vaccines and pharmaceutical and veterinary preparations